TB Research

Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives

Wang H, Wang A, Gu J, Fu L, Lv K, Ma C, Tao Z, Wang B, et al. (11 authors)

European journal of medicinal chemistry · 2018-12

Abstract

A series of reduced lipophilic N-benzylic imidazo[1,2-a]pyridine carboxamides (IPAs) with various side chains were designed and synthesized as new anti-TB agents in this work. Five derivatives A2, A3, A4, B1 and B9 exhibit excellent in vitro activity (MIC: 0-∞ and C max than Q203 and PBTZ169, suggesting its promising potential to be a lead compound for future antitubercular drug discovery.

MeSH terms

  • Mycobacterium tuberculosis
  • Imidazoles
  • Piperazines
  • Pyridines
  • Thiazines
  • Antitubercular Agents
  • Area Under Curve
  • Drug Resistance, Multiple
  • Structure-Activity Relationship
  • Hydrophobic and Hydrophilic Interactions
  • Piperazine